- Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom
- Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand
- The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help seizure patients
- Flora’s cultivation operations are centered at its Colombia facility, and recent regulatory changes there have made it easier for Flora to supply its brands in the United States and elsewhere
On the heels of a year in which global cannabis market brand-builder Flora Growth (NASDAQ: FLGC) saw rapid expansion of its cultivation, manufacturing and distribution operations that support the company’s business divisions for cosmetics, hemp textiles and food and beverage products, Flora is increasing its offerings by bringing a promising CBD brand into its fold and introducing a new product for quality cannabis experiences.
The acquisition of cell biologist Dr. Annabelle Manalo-Morgan’s Masaya brand gives Flora Growth its first offering under its Flora Life Sciences division as well as a patent-pending formulation for use in Flora’s current clinical trials with the University of Manchester in the United Kingdom (https://cnw.fm/05Tev).
The launch of the global clinical trials was announced in October, heralding an effort to study the effects of Flora’s cannabis on fibromyalgia and chronic pain patients (https://cnw.fm/Fu6lQ). Manalo-Morgan developed the formulation for Masaya after her son was born with a condition that led him to suffer from as many as 200 seizures per day.
Manalo-Morgan’s son initially underwent surgery that removed nearly 40 percent of his brain, but Manalo-Morgan’s discovery of CBD’s medicinal potential and development of Masaya’s formulation provided her a non-surgical path for ensuring her son’s well-being.
“He has no developmental deficits. If you saw him, you would never know there was a thing wrong with him. He is not autistic, delayed, nothing. He is a normal 5-year-old boy,” Manalo-Morgan told a news reporter as her son prepared to enter kindergarten last year (https://cnw.fm/DjMth). “If I didn’t do this, my son would most likely be tied to a wheelchair, wouldn’t speak, would still be eating out of a tube. But luckily his mom is a scientist.”
Masaya has been used by thousands of consumers since its development with positive testimonials.
“Amplifying Dr. Annabelle and her son’s beautiful story and improving the well-being of people around the world is our aim,” Flora Chairman and CEO Luis Merchan stated in the company’s news release. “This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for people worldwide.”
On May 18, Flora also announced the development of a custom accessory for cannabis use in collaboration with cannabis lifestyle brand Highsman, which was founded by former NFL running back Ricky Williams.
The patent-pending Highsman Helix one-hitter accessory is the first product introduced under the partnership between Highsman and Flora’s cannabis accessories brand Vessel (https://cnw.fm/ipHTH). It is crafted in non-toxic brass and uniquely designed to offer “the perfect combination of filtering and cooling.”
Vessel’s other luxury accessories include a high-end line of vape pen batteries and dry-herb accessories, while Highsman also markets apparel and other accessories designed to appeal to people with active lifestyles, inspired by Williams’ success.
For more information, visit the company’s website at www.FloraGrowth.com.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
